HOME Top Market Reports In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022

By: marketsandmarkets.com
Publishing Date: September 2017
Report Code: BT 2373

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The In vitro toxicology testing market includes safety assessment of chemicals, drugs, cosmetic products, food additives, etc, without using animals as test models. This testing is performed on advance cell and tissue models to determine safety by studying the potential of the test substances to cause toxicity, such as genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities. The global market was valued at USD 5.99 Billion in 2016 and is expected to grow at a CAGR of 6.6% during the forecast period to reach to USD 8.74 Billion by 2022. The opposition to animal testing, increasing R&D at early stages of drug development, innovation in cell culture technology are factors driving the growth of the global market.

The base year considered for this report is 2016, while 2017 is the estimate year.

Objectives of the Study

  • To define, describe, and forecast the global market by product & service, toxicity endpoint & test, technology, method, industry, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players and comprehensively analyze their core competencies in terms of key market developments, product portfolios, and financials
  • To track and analyze competitive developments such as acquisitions, new product developments, partnerships, agreements, expansions, and collaborations in the global market
  • To benchmark players within the global market using proprietary "Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the In vitro toxicology testing market and estimate the size of other dependent submarkets. Various secondary sources such as Food and Drug Administration (FDA), The United States Environmental Protection Agency (USEPA), National Institute of Environmental Health Sciences (NIEHS), The Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC), Organisation for Economic Co-operation and Development (OECD), The International Association of Forensic Toxicologists (TIAFT), Academic Journals, Company Websites have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

In Vitro Toxicology Testing Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global in vitro toxicology testing market are Cyprotex (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding’s subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), Thermo Fisher Scientific (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), etc.

Target Audience:

  • Drug manufacturers, cosmetic manufacturers, chemical industry, food industry,
  • Academic and government research institutes
  • Contract manufacturing organizations (CMOs) and contract research organizations (CROs)
  • Venture capitalists and investors

Scope of the Report:

The research report categorizes the global market into the following segments and subsegments:

In vitro toxicology testing market, by Products & Services

  • Assays
  • Bacterial toxicity assays
  • Enzyme toxicity assays
  • Cell-based ELISA and western blots
  • Receptor binding assays
  • Tissue culture assays
  • Other assays
  • Services
  • Reagents & labware

* Other assays include: GTPγS-binding Assays, Fluorescent Imaging Plate Reader (FLIPR Assays) (GPCR and Ion Channel Targets), and Various Reporter-based Assay

In vitro toxicology testing market, by Toxicity Endpoints and Tests

  • ADME
  • Skin irritation and sensitization
  • Genotoxicity
  • Cytotoxicity
  • Ocular toxicity
  • Organ toxicity
  • Phototoxicity
  • Dermal toxicity
  • Carcinogenicity
  • Neurotoxicity
  • Other endpoints & tests

*Other Endpoints: ecotoxicity, reproductive toxicity & developmental toxicity, and endocrine disruptors

In vitro toxicology testing market, by Technology

  • Cell culture technology
  • High-throughput technology
  • Cellular imaging technology
  • Toxicogenomics

In vitro toxicology testing market, by Industry

  • Pharmaceuticals & biopharmaceuticals industry
  • Cosmetics and household products industry
  • Food industry
  • Chemicals industry

In vitro toxicology testing market, by Method

  • Cellular Assays
  • Biochemical Assays
  • Ex Vivo Models

In vitro toxicology testing market, by Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Covered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
    2.2 Market Share Estimation
           2.2.1 Secondary Data
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Data
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 35)
    4.1 Global In Vitro Toxicology Testing Market Overview
    4.2 Europe Market: By Technology & Country
    4.3 Global Market: By Country/Region
    4.4 Global Market: Geographic Mix
    4.5 Global Market: Developing vs Developed Markets (USD Billion)

5 Industry Insights (Page No. - 40)
    5.1 Introduction
    5.2 Supply Chain Analysis
    5.3 Regulatory Committee Activities
           5.3.1 Major Stakeholders
           5.3.2 Key Influencers
    5.4 Industry Trends
           5.4.1 Increasing R&D Spending in the Pharmaceutical and Biotechnology Sector
           5.4.2 New and Promising Technological Advancements A Key Area of Focus for Market Players

6 Market Overview (Page No. - 45)
    6.1 Introduction
    6.2 Market Dynamics
           6.2.1 Drivers
                    6.2.1.1 Opposition to Animal Testing
                    6.2.1.2 New and Promising In Vitro Technologies
                    6.2.1.3 Increasing R&D Expenditure to Detect Toxicity at an Early Stage
           6.2.2 Restraints
                    6.2.2.1 Reluctance of Regulatory Authorities to Consider Alternative Methods for Proving Safety and Efficacy
                    6.2.2.2 Failure to Establish Intricacies of In Vivo Conditions Through In Vitro
                    6.2.2.3 Lack of In Vitro Models to Study Complex Endpoints
           6.2.3 Opportunities
                    6.2.3.1 Toxicology in the 21st Century (Tox21) Program
                    6.2.3.2 Increasing Drug Discovery and Innovation & Modernization in the In Vitro Toxicity Testing Market
                    6.2.3.3 Increasing Toxicology Databases Will Facilitate the Use of In Vitro Test Methods
           6.2.4 Challenges
                    6.2.4.1 Dearth of Skilled Professionals

7 In Vitro Toxicology Testing Market, By Product and Service (Page No. - 52)
    7.1 Introduction
    7.2 Assays
           7.2.1 Bacterial Toxicity Assays
           7.2.2 Enzyme Toxicity Assays
           7.2.3 Cell-Based Elisa and Western Blots
           7.2.4 Receptor-Binding Assays
           7.2.5 Tissue Culture Assays
           7.2.6 Other Assays
    7.3 Services
    7.4 Reagents & Labware

8 In Vitro Toxicology Testing Market, By Toxicity Endpoints and Tests (Page No. - 71)
    8.1 Introduction
           8.1.1 ADME (Absorption, Distribution, Metabolism, and Excretion)
           8.1.2 Skin Irritation, Corrosion, and Sensitization
           8.1.3 Genotoxicity Testing
           8.1.4 Cytotoxicity Testing
           8.1.5 Ocular Toxicity
           8.1.6 Organ Toxicity
           8.1.7 Phototoxicity Testing
           8.1.8 Dermal Toxicity
           8.1.9 Carcinogenicity
           8.1.10 Neurotoxicity
           8.1.11 Other Toxicity Endpoints & Tests

9 In Vitro Toxicology Testing Market, By Technology (Page No. - 93)
    9.1 Introduction
    9.2 Cell Culture Technologies
    9.3 High-Throughput Technologies
    9.4 Cellular Imaging Technologies
    9.5 Toxicogenomics

10 In Vitro Toxicology Testing Market, By Industry (Page No. - 103)
     10.1 Introduction
     10.2 Pharmaceutical and Biopharmaceutical Industry
     10.3 Cosmetics and Household Products Industry
     10.4 Food Industry
     10.5 Chemical Industry

11 In Vitro Toxicology Testing Market, By Method (Page No. - 113)
     11.1 Introduction
     11.2 Cellular Assays
     11.3 Biochemical Assays
     11.4 EX Vivo Models

12 In Vitro Toxicology Testing Market, By Region (Page No. - 118)
     12.1 Introduction
     12.2 Europe
             12.2.1 Germany
             12.2.2 UK
             12.2.3 France
             12.2.4 Italy
             12.2.5 Spain
             12.2.6 Rest of Europe (RoE)
     12.3 North America
             12.3.1 US
             12.3.2 Canada
     12.4 Asia Pacific
             12.4.1 Japan
             12.4.2 China
             12.4.3 India
             12.4.4 Rest of Asia Pacific (RoAPAC)
     12.5 Rest of the World (RoW)

13 Competitive Landscape (Page No. - 187)
     13.1 Overview
     13.2 Market Ranking Analysis

14 Company Profiles (Page No. - 188)
(Overview, Products and Services, Financials, Strategy & Development)*
     14.1 SGS S.A.
     14.2 Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
     14.3 Bio-Rad Laboratories, Inc.
     14.4 Qiagen N.V.
     14.5 GE Healthcare
     14.6 Eurofins Scientific Se
     14.7 Merck KGaA
     14.8 Thermo Fisher Scientific, Inc
     14.9 Charles River Laboratories International, Inc.
     14.10 Catalent, Inc.
     14.11 Cyprotex PLC (A Subsidiary of Evotec Ag)
     14.12 Promega Corporation
     14.13 Gentronix Limited
     14.14 Ascendance Biotechnology, Inc.
     14.15 MB Research Laboratories

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. - 244)
     15.1 Insights of Industry Experts
     15.2 Discussion Guide
     15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.4 Introducing RT: Real-Time Market Intelligence
     15.5 Related Reports
     15.6 Author Details


List of Tables (139 Tables)

Table 1 In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 2 Market for Assays, By Type, 2015–2022 (USD Million)
Table 3 Market for Assays, By Country/Region, 2015–2022 (USD Million)
Table 4 Market for Bacterial Toxicity Assays, By Country/Region, 2015–2022 (USD Million)
Table 5 In Vitro Toxicity Testing Market for Enzyme Toxicity Assays, By Country/Region, 2015–2022 (USD Million)
Table 6 Market for Cell-Based Elisa and Western Blots, By Country/Region, 2015–2022 (USD Million)
Table 7 Market for Receptor-Binding Assays, By Country/Region, 2015–2022 (USD Million)
Table 8 In Vitro Toxicology Testing Market for Tissue Culture Assays, By Country/Region, 2015–2022 (USD Million)
Table 9 Market for Other Assays, By Country/Region, 2015–2022 (USD Million)
Table 10 Market for Services, By Country/Region, 2015–2022 (USD Million)
Table 11 Market for Reagents & Labware, By Country/Region, 2015–2022 (USD Million)
Table 12 In Vitro Toxicity Testing Market, By Toxicity Endpoint and Test, 2015–2022 (USD Million)
Table 13 In Vitro Toxicity Testing Market for ADME, By Country/Region, 2015–2022 (USD Million)
Table 14 In Vitro Toxicity Testing Market for Skin Irritation, Corrosion, and Sensitization, By Country/Region, 2015–2022 (USD Million)
Table 15 In Vitro Toxicity Testing Market for Genotoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 16 In Vitro Toxicity Testing Market for Cytotoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 17 In Vitro Toxicity Testing Market for Ocular Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 18 In Vitro Toxicity Testing Market for Organ Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 19 In Vitro Toxicity Testing Market for Phototoxicity Testing, By Country/Region, 2015–2022 (USD Million)
Table 20 In Vitro Toxicity Testing Market for Dermal Toxicity, By Country/Region, 2015–2022 (USD Million)
Table 21 In Vitro Toxicity Testing Market for Carcinogenicity, By Country/Region, 2015–2022 (USD Million)
Table 22 In Vitro Toxicity Testing Market for Neurotoxicity, By Country/Region, 2015–2022 (USD Million)
Table 23 In Vitro Toxicity Testing Market for Other Toxicity Endpoint & Test, By Country/Region, 2015–2022 (USD Million)
Table 24 In Vitro Toxicology Testing Market, By Technology, 2015–2022 (USD Million)
Table 25 Market for Cell Culture Technologies, By Country/Region, 2015–2022 (USD Million)
Table 26 Market for High-Throughput Technologies, By Country/Region, 2015–2022 (USD Million)
Table 27 Market for Cellular Imaging Technologies, By Country/Region, 2015–2022 (USD Million)
Table 28 Market for Toxicogenomics, By Country/Region, 2015–2022 (USD Million)
Table 29 Market, By Industry, 2015–2022 (USD Million)
Table 30 In Vitro Toxicology Testing Market for Pharmaceuticals and Biopharmaceuticals Industry, By Country/Region, 2015–2022 (USD Million)
Table 31 Market for Cosmetics & Household Products Industry, By Country/Region, 2015–2022 (USD Million)
Table 32 Market for the Food Industry, By Country/Region, 2015–2022 (USD Million)
Table 33 Market Size for the Chemical Industry, By Country/Region, 2015–2022 (USD Million)
Table 34 Market, By Method, 2015–2022 (USD Million)
Table 35 Market for Cellular Assays, By Country/Region, 2015–2022 (USD Million)
Table 36 In Vitro Toxicology Testing Market for Biochemical Assays, By Country/Region, 2015–2022 (USD Million)
Table 37 Market for Ex Vivo Assays, By Country/Region, 2015–2022 (USD Million)
Table 38 Market, By Region, 2015–2022 (USD Million)
Table 39 Market, By Country/Region, 2015–2022 (USD Million)
Table 40 Europe: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 41 Europe: Market, By Product and Service, 2015–2022(USD Million)
Table 42 Europe: Market for Assays, By Type, 2015–2022 (USD Million)
Table 43 Europe: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 44 Europe: Market, By Technology, 2015–2022 (USD Million)
Table 45 Europe: Market, By Method, 2015–2022 (USD Million)
Table 46 Europe: Market, By Industry, 2015–2022 (USD Million)
Table 47 Germany: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 48 Germany: Market for Assays, By Type, 2015–2022 (USD Million)
Table 49 Germany: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 50 Germany: Market, By Technology, 2015–2022 (USD Million)
Table 51 Germany: Market, By Method, 2015–2022 (USD Million)
Table 52 Germany: Market, By Industry, 2015–2022 (USD Million)
Table 53 UK: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 54 UK: Market for Assays, By Type, 2015–2022 (USD Million)
Table 55 UK: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 56 UK: Market, By Technology, 2015–2022 (USD Million)
Table 57 UK: Market, By Method, 2015–2022 (USD Million)
Table 58 UK: Market, By Industry, 2015–2022 (USD Million)
Table 59 France: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 60 France: Market for Assays, By Type, 2015–2022 (USD Million)
Table 61 France: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 62 France: Market, By Technology, 2015–2022 (USD Million)
Table 63 France: Market, By Method, 2015–2022 (USD Million)
Table 64 France: Market, By Industry, 2015–2022 (USD Million)
Table 65 Italy: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022 (USD Million)
Table 66 Italy: Market for Assays, By Type, 2015–2022 (USD Million)
Table 67 Italy: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 68 Italy: Market, By Technology, 2015–2022 (USD Million)
Table 69 Italy: Market, By Method, 2015–2022 (USD Million)
Table 70 Italy: Market, By Industry, 2015–2022 (USD Million)
Table 71 Spain: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 72 Spain: Market for Assays, By Type, 2015–2022 (USD Million)
Table 73 Spain: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 74 Spain: Market, By Technology, 2015–2022 (USD Million)
Table 75 Spain: Market, By Method, 2015–2022 (USD Million)
Table 76 Spain: Market, By Industry, 2015–2022 (USD Million)
Table 77 RoE: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 78 RoE: Market for Assays, By Type, 2015–2022 (USD Million)
Table 79 RoE: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 80 RoE: Market, By Technology, 2015–2022 (USD Million)
Table 81 RoE: Market, By Method, 2015–2022 (USD Million)
Table 82 RoE: Market, By Industry, 2015–2022 (USD Million)
Table 83 North America: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 84 North America: Market, By Product and Service, 2015–2022(USD Million)
Table 85 North America: Market for Assays, By Type, 2015–2022 (USD Million)
Table 86 North America: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 87 North America: Market, By Technology, 2015–2022 (USD Million)
Table 88 North America: Market, By Method, 2015–2022 (USD Million)
Table 89 North America: Market, By Industry, 2015–2022 (USD Million)
Table 90 US: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 91 US: Market for Assays, By Type, 2015–2022 (USD Million)
Table 92 US: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 93 US: Market, By Technology, 2015–2022 (USD Million)
Table 94 US: Market, By Method, 2015–2022 (USD Million)
Table 95 US: Market, By Industry, 2015–2022 (USD Million)
Table 96 Canada: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 97 Canada: Market for Assays, By Type, 2015–2022 (USD Million)
Table 98 Canada: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 99 Canada: Market, By Technology, 2015–2022 (USD Million)
Table 100 Canada: Market, By Method, 2015–2022 (USD Million)
Table 101 Canada: Market, By Industry, 2015–2022 (USD Million)
Table 102 APAC: In Vitro Toxicology Testing Market, By Country/Region, 2015–2022 (USD Million)
Table 103 APAC: Market, By Product and Service, 2015–2022(USD Million)
Table 104 APAC: Market for Assays, By Type, 2015–2022 (USD Million)
Table 105 APAC: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 106 APAC: Market, By Technology, 2015–2022 (USD Million)
Table 107 APAC: Market, By Method, 2015–2022 (USD Million)
Table 108 APAC: Market, By Industry, 2015–2022 (USD Million)
Table 109 Japan: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 110 Japan: Market for Assays, By Type, 2015–2022 (USD Million)
Table 111 Japan: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 112 Japan: Market, By Technology, 2015–2022 (USD Million)
Table 113 Japan: Market, By Method, 2015–2022 (USD Million)
Table 114 Japan: Market, By Industry, 2015–2022 (USD Million)
Table 115 China: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 116 China: Market for Assays, By Type, 2015–2022 (USD Million)
Table 117 China: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 118 China: Market, By Technology, 2015–2022 (USD Million)
Table 119 China: Market, By Method, 2015–2022 (USD Million)
Table 120 China: Market, By Industry, 2015–2022 (USD Million)
Table 121 India: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 122 India: Market for Assays, By Type, 2015–2022 (USD Million)
Table 123 India: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 124 India: Market, By Technology, 2015–2022 (USD Million)
Table 125 India: Market, By Method, 2015–2022 (USD Million)
Table 126 India: Market, By Industry, 2015–2022 (USD Million)
Table 127 RoAPAC: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 128 RoAPAC: Market for Assays, By Type, 2015–2022 (USD Million)
Table 129 RoAPAC: Market, By Toxicity Endpoint & Tests, 2015–2022 (USD Million)
Table 130 RoAPAC: Market, By Technology, 2015–2022 (USD Million)
Table 131 RoAPAC: Market, By Method, 2015–2022 (USD Million)
Table 132 RoAPAC: Market, By Industry, 2015–2022 (USD Million)
Table 133 RoW: In Vitro Toxicology Testing Market, By Product and Service, 2015–2022(USD Million)
Table 134 RoW: Market for Assays, By Type, 2015–2022 (USD Million)
Table 135 RoW: Market, By Toxicity Endpoint & Test, 2015–2022 (USD Million)
Table 136 RoW: Market, By Technology, 2015–2022 (USD Million)
Table 137 RoW: Market, By Method, 2015–2022 (USD Million)
Table 138 RoW: Market, By Industry, 2015–2022 (USD Million)
Table 139 Rank of Companies in the In Vitro Toxicology Testing Market, 2016


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 In Vitro Toxicology Testing Market, By Product and Service, 2017 vs 2022 (USD Billion)
Figure 7 Market, By Toxicity Endpoint & Test, 2017 vs 2022 (USD Million)
Figure 8 Global Market, By Technology, 2017 vs 2022 (USD Billion)
Figure 9 Market, By Method, 2017 vs 2022 (USD Billion)
Figure 10 In Vitro Toxicology Testing Market, By Industry, 2017 vs 2022 (USD Billion)
Figure 11 Geographical Snapshot of the Global Market, 2017
Figure 12 Opposition to Animal Testing and Increase in R&D Spending to Drive Market Growth
Figure 13 Toxicogenomics Technologies is Expected to Command the Largest Market Share in 2017
Figure 14 China to Register Highest Growth During the Forecast Period
Figure 15 Europe Holds the Highest Market Share During the Forecast Period
Figure 16 Developing Markets to Grow at the Highest CAGRs From 2017 to 2022
Figure 17 Supply Chain Analysis: In Vitro Toxicology Testing Market (As of 2016)
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Global Market Snapshot (2017)
Figure 20 Europe: Market Snapshot, 2017 (USD Million)
Figure 21 Asia Pacific: In Vitro Toxicology Testing Market Snapshot (2017)
Figure 22 SGS S.A.: Company Snapshot (2016)
Figure 23 Laboratory Corporation of America Holdings: Company Snapshot (2016)
Figure 24 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 25 Qiagen N.V.: Company Snapshot (2016)
Figure 26 GE Healthcare: Company Snapshot (2016)
Figure 27 Eurofins Scientific Se: Company Snapshot (2016)
Figure 28 Merck KGaA: Company Snapshot (2016)
Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2016)
Figure 30 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 31 Catalent, Inc.: Company Snapshot (2016)
Figure 32 Evotec AG: Company Snapshot (2016)

The In vitro toxicology testing market is projected to reach USD 8.74 Billion by 2022 from USD 6.34 Billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage.

The report analyzes the global market by products & services, toxicity endpoints and tests, technology, industry, methods, and region.

Based on toxicity endpoints and tests of in vitro toxicology testing, the market is subsegmented into ADME, genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities (eco toxicity, endocrine disruption, and reproductive & developmental toxicity). In 2017, the ADME segment is expected to account for the largest share of the global in vitro toxicology testing market owing to its highly reproducible & accurate data and the increasing demand to curb drug toxicity at the drug development phase.

Based on industry, the global market is segmented into pharmaceuticals and biopharmaceuticals, cosmetics & household products, food, and chemicals. In 2017, the pharmaceutical and biopharmaceutical industry segment is expected to account for the largest share of the global market. The new research initiatives, mandatory preclinical safety evaluation of molecules, and growing R&D for detecting toxicity in the early stages of drug development are the primary growth drivers for this industry segment.

In Vitro Toxicology Testing Market

Based on region, the in vitro toxicology testing market is segmented into Europe, North America, Asia Pacific, and the RoW. In 2017, Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.

However, the reluctance of regulatory bodies to consider in vitro test results over in vivo and failure to produce comparable results from in vitro testing to that with in vivo testing are factors that may hinder the growth of this market.

In 2017, Thermo Fisher Scientific, Inc. (US) is expected to dominate the in vitro toxicology testing market. Some of the other players competing in this market are Cyprotex (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding’s subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), etc.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo